{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:08:10Z","timestamp":1787501290551,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.repc.2021.12.011","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T05:41:42Z","timestamp":1657950102000},"page":"813-819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pirfenidone alleviates vascular intima injury caused by hyperhomocysteinemia"],"prefix":"10.1016","volume":"41","author":[{"given":"Junying","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2021.12.011_bib0215","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1172\/JCI10588","article-title":"Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model","volume":"107","author":"Hofmann","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.repc.2021.12.011_bib0220","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0021-9150(03)00138-2","article-title":"Effects of vitamin supplementation and hyperhomocysteinemia on atherosclerosis in apoE-deficient mice","volume":"168","author":"Zhou","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.repc.2021.12.011_bib0225","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/j.2040-4603.2016.tb00682.x","article-title":"Homocysteine metabolism, atherosclerosis, and diseases of aging","volume":"6","author":"McCully","year":"2015","journal-title":"Compr Physiol"},{"key":"10.1016\/j.repc.2021.12.011_bib0230","doi-asserted-by":"crossref","first-page":"e94935","DOI":"10.1371\/journal.pone.0094935","article-title":"Homocysteine and carotid plaque stability: a cross-sectional study in Chinese adults","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.repc.2021.12.011_bib0235","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/biof.17","article-title":"Contributions of hyperhomocysteinemia to atherosclerosis: causal relationship and potential mechanisms","volume":"35","author":"Ji Zhou","year":"2009","journal-title":"Biofactors"},{"key":"10.1016\/j.repc.2021.12.011_bib0240","doi-asserted-by":"crossref","first-page":"109729","DOI":"10.1016\/j.biopha.2019.109729","article-title":"Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-\/-) mice by activating PI3K\/AKT signaling and suppressing TRL4\/NF-kappaB signaling","volume":"123","author":"Wang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.repc.2021.12.011_bib0245","doi-asserted-by":"crossref","first-page":"110399","DOI":"10.1016\/j.biopha.2020.110399","article-title":"Ziziphora clinopodioides flavonoids based on network pharmacology attenuates atherosclerosis in rats induced by high-fat emulsion combined with vitamin D(3) by down-regulating VEGF\/AKT\/NF-kappaB signaling pathway","volume":"129","author":"Wu","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.repc.2021.12.011_bib0250","doi-asserted-by":"crossref","first-page":"120199","DOI":"10.1016\/j.biomaterials.2020.120199","article-title":"Construction and application of therapeutic metal-polyphenol capsule for peripheral artery disease","volume":"255","author":"Duan","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.repc.2021.12.011_bib0255","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jvs.2004.09.021","article-title":"Curcumin blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries","volume":"40","author":"Ramaswami","year":"2004","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.repc.2021.12.011_bib0260","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00348-2020","article-title":"Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial","volume":"57","author":"Sakamoto","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.repc.2021.12.011_bib0265","doi-asserted-by":"crossref","first-page":"190021","DOI":"10.1183\/16000617.0021-2019","article-title":"The therapy of idiopathic pulmonary fibrosis: what is next?","volume":"28","author":"Somogyi","year":"2019","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.repc.2021.12.011_bib0270","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s10020-020-00173-3","article-title":"Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt\/GSK-3beta\/beta-catenin and TGF-beta1\/Smad2\/3 signaling pathways","volume":"26","author":"Lv","year":"2020","journal-title":"Mol Med"},{"key":"10.1016\/j.repc.2021.12.011_bib0275","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s00228-020-02947-4","article-title":"The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2: anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection?","volume":"76","author":"Ferrara","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.repc.2021.12.011_bib0280","doi-asserted-by":"crossref","first-page":"19936","DOI":"10.1038\/s41598-020-76271-3","article-title":"Pirfenidone regulates LPS mediated activation of neutrophils","volume":"10","author":"Evani","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.repc.2021.12.011_bib0285","doi-asserted-by":"crossref","first-page":"102464","DOI":"10.1016\/j.jaut.2020.102464","article-title":"Pirfenidone alleviates lipopolysaccharide-induced lung injury by accentuating BAP31 regulation of ER stress and mitochondrial injury","volume":"112","author":"Du","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.repc.2021.12.011_bib0290","doi-asserted-by":"crossref","first-page":"107593","DOI":"10.1016\/j.intimp.2021.107593","article-title":"Pirfenidone mediates cigarette smoke extract induced inflammation and oxidative stress in vitro and in vivo","volume":"96","author":"Ma","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.repc.2021.12.011_bib0295","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.TP.0000151721.99418.48","article-title":"Effect of pirfenidone on apoptosis-regulatory genes in chronic cyclosporine nephrotoxicity","volume":"79","author":"Shihab Fuad","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.repc.2021.12.011_bib0300","first-page":"1081","article-title":"Pirfenidone attenuates homocysteineinduced apoptosis by regulating the connexin 43 pathway in H9C2 cells","volume":"45","author":"Chen","year":"2020","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.repc.2021.12.011_bib0305","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/ejvs.2001.1574","article-title":"Pirfenidone inhibits early myointimal proliferation but has no effect on late lesion size in rats","volume":"23","author":"Waller","year":"2002","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.repc.2021.12.011_bib0310","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/FJC.0b013e3181ce97f6","article-title":"Inhibition of matrix deposition: a new strategy for prevention of restenosis after balloon angioplasty","volume":"55","author":"Backes","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.repc.2021.12.011_bib0315","doi-asserted-by":"crossref","first-page":"104694","DOI":"10.1016\/j.phrs.2020.104694","article-title":"Pirfenidone is a cardioprotective drug: mechanisms of action and preclinical evidence","volume":"155","author":"Aimo","year":"2020","journal-title":"Pharmacol Res"},{"issue":"7\u20138","key":"10.1016\/j.repc.2021.12.011_bib0320","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/S0041-1345(01)02615-X","article-title":"Effects of pirfenidone on vascular smooth muscle cell proliferation and intimal hyperplasia following arterial balloon injury","volume":"33","author":"Waller","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.repc.2021.12.011_bib0325","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00011-012-0568-x","article-title":"Urinary trypsin inhibitor reduced neointimal hyperplasia induced by systemic inflammation after balloon injury in rabbits","volume":"62","author":"Kong","year":"2013","journal-title":"Inflamm Res"},{"key":"10.1016\/j.repc.2021.12.011_bib0330","first-page":"386","article-title":"Effects of high methionine diet on oxidative stress in serum, apo-B containing lipoproteins, heart, and aorta in rabbits","volume":"39","author":"Yal\u00e7inkaya-Demirs\u00f6z","year":"2009","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.repc.2021.12.011_bib0335","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1369\/jhc.5A6677.2005","article-title":"The immunoquantification of caveolin-1 and eNOS in human and rabbit diseased blood vessels","volume":"54","author":"Zulli","year":"2006","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.repc.2021.12.011_bib0340","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jacc.2011.05.028","article-title":"Homocysteine and reclassification of cardiovascular disease risk","volume":"58","author":"Veeranna","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2021.12.011_bib0345","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/jcmm.12510","article-title":"Rosiglitazone via PPAR\u03b3-dependent suppression of oxidative stress attenuates endothelial dysfunction in rats fed homocysteine thiolactone","volume":"19","author":"Yang","year":"2015","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.repc.2021.12.011_bib0350","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/1755-5922.12234","article-title":"Salidroside protects against homocysteine-induced injury in HUVECs via the regulation of endoplasmic reticulum stress","volume":"35","author":"Zhu","year":"2017","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.repc.2021.12.011_bib0355","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1161\/01.CIR.103.22.2717","article-title":"Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells implications for vascular disease","volume":"103","author":"Poddar","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2021.12.011_bib0360","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/jdi.12516","article-title":"Berberine activates peroxisome proliferator-activated receptor gamma to increase atherosclerotic plaque stability in Apoe-\/- mice with hyperhomocysteinemia","volume":"7","author":"Li","year":"2016","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.repc.2021.12.011_bib0365","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.biopha.2016.02.022","article-title":"Alpha-lipoic acid defends homocysteine-induced endoplasmic reticulum and oxidative stress in HAECs","volume":"80","author":"Hu","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.repc.2021.12.011_bib0370","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1007\/s12325-020-01474-z","article-title":"Folic acid supplementation in patients with elevated homocysteine levels","volume":"37","author":"Kaye","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.repc.2021.12.011_bib0375","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1474-4422(04)00826-9","article-title":"Homocysteine, B-vitamin supplementation, and stroke prevention: from observational to interventional trials","volume":"3","author":"Schwammenthal","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.repc.2021.12.011_bib0380","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med."},{"issue":"1\u20133","key":"10.1016\/j.repc.2021.12.011_bib0385","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0014-2999(02)01758-2","article-title":"A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-alpha at the translational level","volume":"446","author":"Nakazato","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.repc.2021.12.011_bib0390","doi-asserted-by":"crossref","first-page":"e28134","DOI":"10.1371\/journal.pone.0028134","article-title":"In vitro effects of pirfenidone on cardiac fibroblasts: proliferation, myofibroblast differentiation, migration and cytokine secretion","volume":"6","author":"Shi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.repc.2021.12.011_bib0395","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1128\/IAI.70.6.2989-2994.2002","article-title":"Pirfenidone blocks the in vitro and in vivo effects of staphylococcal enterotoxin B","volume":"70","author":"Hale Martha","year":"2002","journal-title":"IAI"},{"key":"10.1016\/j.repc.2021.12.011_bib0400","doi-asserted-by":"crossref","first-page":"118454","DOI":"10.1016\/j.lfs.2020.118454","article-title":"Pirfenidone attenuates gentamicin-induced acute kidney injury by inhibiting inflammasome-dependent NLRP3 pathway in rats","volume":"260","author":"Sharawy","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.repc.2021.12.011_bib0405","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41374-019-0255-4","article-title":"Pirfenidone prevents and reverses hepatic insulin resistance and steatohepatitis by polarizing M2 macrophages","volume":"99","author":"Chen","year":"2019","journal-title":"Lab Invest"},{"key":"10.1016\/j.repc.2021.12.011_bib0410","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41598-018-37438-1","article-title":"Mitochondrial dysfunction in aged macrophages and lung during primary streptococcus pneumoniae infection is improved with pirfenidone","volume":"9","author":"Plataki","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.repc.2021.12.011_bib0415","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s10753-018-0873-9","article-title":"Catalpol inhibits homocysteine-induced oxidation and inflammation via inhibiting Nox4\/NF-kappaB and GRP78\/PERK pathways in human aorta endothelial cells","volume":"42","author":"Hu","year":"2019","journal-title":"Inflammation"},{"key":"10.1016\/j.repc.2021.12.011_bib0420","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/jcmm.16073","article-title":"Gastrodin prevents homocysteine-induced human umbilical vein endothelial cells injury via PI3K\/Akt\/eNOS and Nrf2\/ARE pathway","volume":"25","author":"Chen","year":"2021","journal-title":"J Cell Mol Med"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255122002542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255122002542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:11:21Z","timestamp":1760109081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255122002542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0870255122002542"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2021.12.011","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pirfenidone alleviates vascular intima injury caused by hyperhomocysteinemia","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2021.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}